2003-2004 Review of Anticoagulants, Thrombolytics and Anti-platelet Drugs 4 October 2015 8:06 PM.

2003-2004Review of Anticoagulants,

Thrombolytics and Anti-platelet Drugs

April 19, 202307:58 PM

Abciximab

Antiplatelet

Anti-GPIIb/IIIa receptor antibody

Anistreplase

Thrombolytic

Streptokinase + plasminogen

Argatroban

Anticoagulant

Direct thrombin inhibitor

Aspirin(Acetylsalicylic acid, ASA)

NSAID (acetylsalicylate)Analgesic, Anti-inflammatory

Antipyretic, Antiplatelet

Irreversible cyclooxygenase inhibitor

Bivalirudin

Anticoagulant

Direct thrombin inhibitor

Clopidogrel

Antiplatelet

ADP receptor antagonist

Dalteparin

Anticoagulant

LMW HeparinATIII activator

Dipyridamole

Antiplatelet

Phosphodiesterase inhibitor(increases cAMP)

Drotrecogin alfa(Activated Protein C)

Anticoagulant

Many actionsTreatment for septic shock

Enoxaparin

Anticoagulant

LMW HeparinATIII activator

Eptifibatide

Antiplatelet

GPIIb/IIIa antagonist

Heparin

Anticoagulant

ATIII activator

Hirudin

Anticoagulant

Direct thrombin inhibitor(DTI)

4-Hydroxycoumarin

Oral anticoagulant

Vitamin K synthesis inhibitor

Lepirudin

Anticoagulant

Direct thrombin inhibitor (DTI)

Protamine Sulfate

Heparin antagonist

Streptokinase

Thrombolytic

Ticlopidine

Antiplatelet

ADP receptor antagonist

Tissue plasminogen activators

Thrombolytics

alteplase, reteplase, tenecteplase

Urokinase

Thrombolytic

Warfarin

Anticoagulant

Vitamin K synthesis inhibitor